Clinical Trials Browser

Phase NA × Specimen Handling × Gynecologic × Clear all

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT06498661 2026-05-13

SHIP-A-S01

Phase NA Active not recruiting

750 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

Phase NA Active not recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

Phase NA Active not recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281430 2026-05-13

LMI-001-A-S04

Phase NA Recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04251052 2026-03-27

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Phase NA Recruiting

1,956 enrolled

Gynecologic

Ovarian Neoplasms

NCT06855706 2026-01-06

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Phase NA Recruiting

120 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05047926 2025-08-08

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Phase NA Completed

90 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Phase NA Completed

152 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Clinical Trials

The Vanguard Study: Testing a New Way to Screen for Cancer

SHIP-A-S01

LMI-001-A-S03

LMI-001-A-S02

LMI-001-A-S04

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study